U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021926

Expand all

TREXIMET (NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE)
500MG;EQ 85MG BASE
Marketing Status: Prescription
Active Ingredient: NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Proprietary Name: TREXIMET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;EQ 85MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N021926
Product Number: 001
Approval Date: Apr 15, 2008
Applicant Holder Full Name: CURRAX PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
TREXIMET (NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE)
60MG;EQ 10MG BASE
Marketing Status: Discontinued
Active Ingredient: NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Proprietary Name: TREXIMET
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 60MG;EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N021926
Product Number: 002
Approval Date: May 14, 2015
Applicant Holder Full Name: CURRAX PHARMACEUTICALS LLC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top